Login Register Cart 0
Generic placeholder image

Current Protein & Peptide Science

Editor-in-Chief

ISSN (Print): 1389-2037
ISSN (Online): 1875-5550

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Japanese Cedar Pollen Allergens in Japan

Author(s): Katsuyo Ohashi-Doi*, Daichi Utsumi, Yuko Mitobe and Koji Fujinami

Volume 23, Issue 12, 2022

Published on: 02 November, 2022

Page: [837 - 850] Pages: 14

DOI: 10.2174/1389203723666220930155719

Price: $65

Abstract

Pollen from members of the Cupressaceae tree family is one of the most important causes of allergic disease in the world. Cryptomeria japonica (Japanese cedar) and Chamaecyparis obtusa (Japanese cypress) are Japan's most common tree species. The pollen dispersal season is mainly from February to May. The major allergens of Japanese cedar and Japanese cypress exhibit high amino acid sequence similarity due to the phylogenetic relationship between the two species. An epidemiological study has shown that the prevalence of Japanese cedar pollinosis is approximately 40%. Younger children (5 to 9 years old) showed a high prevalence of Japanese cedar pollinosis as 30% in 2019, indicating that season pollinosis is getting worse. Pharmacotherapy is the most common treatment for pollinosis induced by Japanese cedar and Japanese cypress. Patients’ satisfaction with pharmacotherapy is low due to insufficient experienced effect and daytime somnolence. Unlike pharmacotherapy, allergy immunotherapy (AIT) addresses the basic immunological mechanisms of allergic disease and activates protective allergen-reactive pathways of the immune system. AIT is now recognized as the only treatment option with the potential to provide long-term post-treatment benefits and alter the natural course of the allergic disease, including Japanese cedar pollinosis.

Keywords: Cupressaceae family, Pollinosis, Japanese cedar, Major allergen, Homology

« Previous Next »
[1]
Pawankar, R.; Canonica, G.W.; Holgate, S.T.; Lockey, R.F.; Blaiss, M.M. WAO White Book on Allergy | World Allergy Organization. Available from: https://www.worldallergy.org/wao-white-book-on-allergy
[2]
Brożek, J.L.; Bousquet, J.; Agache, I.; Agarwal, A.; Bachert, C.; Bosnic-Anticevich, S.; Brignardello-Petersen, R.; Canonica, G.W.; Casale, T.; Chavannes, N.H.; Correia de Sousa, J.; Cruz, A.A.; Cuello-Garcia, C.A.; Demoly, P.; Dykewicz, M.; Etxeandia-Ikobaltzeta, I.; Florez, I.D.; Fokkens, W.; Fonseca, J.; Hellings, P.W.; Klimek, L.; Kowalski, S.; Kuna, P.; Laisaar, K.T.; Larenas-Linnemann, D.E. Lødrup Carl-sen, K.C.; Manning, P.J.; Meltzer, E.; Mullol, J.; Muraro, A.; O’Hehir, R.; Ohta, K.; Panzner, P.; Papadopoulos, N.; Park, H.S.; Passalac-qua, G.; Pawankar, R.; Price, D.; Riva, J.J.; Roldán, Y.; Ryan, D.; Sadeghirad, B.; Samolinski, B.; Schmid-Grendelmeier, P.; Sheikh, A.; To-gias, A.; Valero, A.; Valiulis, A.; Valovirta, E.; Ventresca, M.; Wallace, D.; Waserman, S.; Wickman, M.; Wiercioch, W.; Yepes-Nuñez, J.J.; Zhang, L.; Zhang, Y.; Zidarn, M.; Zuberbier, T.; Schünemann, H.J. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 re-vision. J. Allergy Clin. Immunol., 2017, 140(4), 950-958.
[http://dx.doi.org/10.1016/j.jaci.2017.03.050] [PMID: 28602936]
[3]
Canonica, G.W.; Cox, L.; Pawankar, R.; Baena-Cagnani, C.E.; Blaiss, M.; Bonini, S.; Bousquet, J.; Calderón, M.; Compalati, E.; Durham, S.R.; van Wijk, R.G.; Larenas-Linnemann, D.; Nelson, H.; Passalacqua, G.; Pfaar, O.; Rosário, N.; Ryan, D.; Rosenwasser, L.; Schmid-Grendelmeier, P.; Senna, G.; Valovirta, E.; Van Bever, H.; Vichyanond, P.; Wahn, U.; Yusuf, O. Sublingual immunotherapy: World allergy organization position paper 2013 update. World Allergy Organ. J., 2014, 7(1), 6.
[http://dx.doi.org/10.1186/1939-4551-7-6] [PMID: 24679069]
[4]
Global Strategy for Asthma Management and Prevention. 2018. Available from: https://ginasthma.org/
[5]
Di Felice, G.; Barletta, B.; Tinghino, R.; Pini, C. Cupressaceae pollinosis: Identification, purification and cloning of relevant allergens. Int. Arch. Allergy Immunol., 2001, 125(4), 280-289.
[http://dx.doi.org/10.1159/000053828] [PMID: 11574749]
[6]
Weber, R.W. Patterns of pollen cross allergenicity. J. Allergy Clin. Immunol., 2003, 112(2), 229-239.
[http://dx.doi.org/10.1067/mai.2003.1683] [PMID: 12897724]
[7]
Charpin, D.; Calleja, M.; Lahoz, C.; Pichot, C.; Waisel, Y. Allergy to cypress pollen. Allergy, 2005, 60(3), 293-301.
[http://dx.doi.org/10.1111/j.1398-9995.2005.00731.x] [PMID: 15679713]
[8]
Charpin, D.; Pichot, C.; Belmonte, J.; Sutra, J.P.; Zidkova, J.; Chanez, P.; Shahali, Y.; Sénéchal, H.; Poncet, P. Cypress pollinosis: From tree to clinic. Clin. Rev. Allergy Immunol., 2019, 56(2), 174-195.
[http://dx.doi.org/10.1007/s12016-017-8602-y] [PMID: 28401436]
[9]
Mao, K.; Milne, R.I.; Zhang, L.; Peng, Y.; Liu, J.; Thomas, P.; Mill, R.R.; Renner, S.S. Distribution of living Cupressaceae reflects the breakup of Pangea. Proc. Natl. Acad. Sci. USA, 2012, 109(20), 7793-7798.
[http://dx.doi.org/10.1073/pnas.1114319109] [PMID: 22550176]
[10]
Minami, T.; Fukutomi, Y.; Inada, R.; Tsuda, M.; Sekiya, K.; Miyazaki, M.; Tsuji, F.; Taniguchi, M. Regional differences in the prevalence of sensitization to environmental allergens: Analysis on IgE antibody testing conducted at major clinical testing laboratories throughout Ja-pan from 2002 to 2011. Allergol. Int., 2019, 68(4), 440-449.
[http://dx.doi.org/10.1016/j.alit.2019.03.008] [PMID: 31036486]
[11]
Schwietz, L.A.; Goetz, D.W.; Whisman, B.A.; Reid, M.J. Cross-reactivity among conifer pollens. Ann. Allergy Asthma Immunol., 2000, 84(1), 87-93.
[http://dx.doi.org/10.1016/S1081-1206(10)62746-9] [PMID: 10674571]
[12]
Yamada, T.; Saito, H.; Fujieda, S. Present state of Japanese cedar pollinosis: The national affliction. J. Allergy Clin. Immunol., 2014, 133(3), 632-639.e5.
[http://dx.doi.org/10.1016/j.jaci.2013.11.002] [PMID: 24361081]
[13]
Ito, Y.; Hattori, R.; Mase, H.; Watanabe, M.; Shiotani, I. Forecasting models for sugi (Cryptomeria japonica D. Don) pollen count showing an alternate dispersal rhythm. Allergol. Int., 2008, 57(4), 321-329.
[http://dx.doi.org/10.2332/allergolint.O-07-520] [PMID: 18690007]
[14]
Kishikawa, R.; Kotoh, E.; Oshikawa, C.; Soh, N.; Shimoda, T.; Saito, A.; Sahashi, N.; Enomoto, T.; Usami, A.; Teranishi, H.; Fujisaki, Y.; Yokoyama, T.; Murayama, K.; Imai, T.; Fukutomi, Y.; Taniguchi, M.; Iwanaga, T. Longitudinal monitoring of tree airborne pollen in Ja-pan. Arerugi, 2017, 66(2), 97-111.
[http://dx.doi.org/10.15036/arerugi.66.97] [PMID: 28331111]
[15]
Taira, H.; Teranishi, H.; Kenda, Y. Comparison of predictive methods of Sugi (Cryptomeria) atmospheric pollen counts using mean tem-perature, solar radiation and male flowering index-an example of Toyama Prefecture. Arerugi, 1997, 46(6), 489-495.
[PMID: 9276999]
[16]
Takahashi, Y.; Kawashima, S. A new prediction method for the total pollen counts of Cryptomeria japonica based on variation in annual summertime temperature. Arerugi, 1999, 48(11), 1217-1221.
[http://dx.doi.org/10.15036/arerugi.48.1217] [PMID: 10630021]
[17]
Yuta, A.; Ukai, K.; Sakakura, Y.; Tani, H.; Matsuda, F.; Yang, T.Q.; Majima, Y. Prediction of the total Japanese cedar pollen counts based on male flower-setting conditions of standard trees. Arerugi, 2002, 51(7), 577-582.
[PMID: 12201172]
[18]
Yamazaki, F. Studies of the pollen grains causing pollinosis (10). Correlation between sugi pollinosis and mean ten day temperature in July. Arerugi, 1985, 34(5), 305-309.
[PMID: 4038082]
[19]
Shah, S.A.; Takeuchi, K. Association between Japanese cedar and cypress pollen counts and climate factors over a 10-year period in Tsu city. Aerobiologia, 2020, 36, 291-297.
[http://dx.doi.org/10.1007/s10453-020-09632-0]
[20]
Osada, T.; Okano, M. Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment. Allergol. Int., 2021, 70(3), 281-290.
[http://dx.doi.org/10.1016/j.alit.2021.04.002] [PMID: 33962864]
[21]
Horiguchi, S.; Saito, Y. Japanese cedar pollinosis in Nikko, Japan. Jpn. J. Allergol., 1964, (13), 16-18.
[http://dx.doi.org/10.15036/arerugi.13.16]
[22]
The official web portal of Government of Japan: Basic act on allergic diseases measures. Available from: https://elaws.e-gov.go.jp/document?lawid=426AC1000000098
[23]
Matsubara, A.; Sakashita, M.; Gotoh, M.; Kawashima, K.; Matsuoka, T.; Kondo, S.; Yamada, T.; Takeno, S.; Takeuchi, K.; Urashima, M.; Fujieda, S.; Okubo, K. Epidemiological survey of allergic rhinitis in Japan 2019. Nippon Jibiinkoka Gakkai Kaiho, 2020, 123(6), 485-490.
[http://dx.doi.org/10.3950/jibiinkoka.123.485]
[24]
Fujimura, T.; Kawamoto, S. Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy. Allergol. Int., 2015, 64(4), 312-320.
[http://dx.doi.org/10.1016/j.alit.2015.05.008] [PMID: 26433527]
[25]
Kucuksezer, U.C.; Ozdemir, C.; Cevhertas, L.; Ogulur, I.; Akdis, M.; Akdis, C.A. Mechanisms of allergen-specific immunotherapy and allergen tolerance. Allergol. Int., 2020, 69(4), 549-560.
[http://dx.doi.org/10.1016/j.alit.2020.08.002] [PMID: 32900655]
[26]
Couroux, P.; Ipsen, H.; Stage, B.S.; Damkjaer, J.T.; Steffensen, M.A.; Salapatek, A.M.; Lund, K.; Würtzen, P.A. A birch sublingual allergy immunotherapy tablet reduces rhinoconjunctivitis symptoms when exposed to birch and oak and induces IgG 4 to allergens from all trees in the birch homologous group. Allergy, 2019, 74(2), 361-369.
[http://dx.doi.org/10.1111/all.13606] [PMID: 30229939]
[27]
Würtzen, P.A.; Grønager, P.M.; Lund, G.; Gupta, S.; Andersen, P.S.; Biedermann, T.; Ipsen, H. Simplified AIT for allergy to several tree pollens-Arguments from the immune outcome analyses following treatment with SQ tree SLIT‐tablet. Clin. Exp. Allergy, 2021, 51(2), 284-295.
[http://dx.doi.org/10.1111/cea.13788] [PMID: 33207015]
[28]
Caraballo, L.; Valenta, R.; Acevedo, N.; Zakzuk, J. Are the terms major and minor allergens useful for precision allergology? Front. Immunol., 2021, 12, 651500.
[http://dx.doi.org/10.3389/fimmu.2021.651500] [PMID: 33763086]
[29]
Allergen nomenclature. Available from: http://allergen.org
[30]
Hashimoto, M.; Nigi, H.; Sakaguchi, M.; Inouye, S.; Imaoka, K.; Miyazawa, H.; Taniguchi, Y.; Kurimoto, M.; Yasueda, H.; Ogawa, T. Sensitivity to two major allergens (Cry j I and Cry j II) in patients with Japanese cedar (Cryptomeria japonica) pollinosis. Clin. Exp. Allergy, 1995, 25(9), 848-852.
[http://dx.doi.org/10.1111/j.1365-2222.1995.tb00027.x] [PMID: 8564723]
[31]
Sone, T.; Morikubo, K.; Miyahara, M.; Komiyama, N.; Shimizu, K.; Tsunoo, H.; Kino, K. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis. J. Immunol., 1998, 161(1), 448-457.
[PMID: 9647255]
[32]
Yasueda, H.; Yui, Y.; Shimizu, T.; Shida, T. Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen. J. Allergy Clin. Immunol., 1983, 71(1 Pt 1), 77-86.
[http://dx.doi.org/10.1016/0091-6749(83)90550-X] [PMID: 6822692]
[33]
Maeda, M.; Kamamoto, M.; Hino, K.; Yamamoto, S.; Kimura, M.; Okano, M.; Kimura, Y. Glycoform analysis of Japanese cedar pollen allergen, Cry j 1. Biosci. Biotechnol. Biochem., 2005, 69(9), 1700-1705.
[http://dx.doi.org/10.1271/bbb.69.1700] [PMID: 16195587]
[34]
Miki-Hirosige, H.; Nakamura, S.; Yasueda, H.; Shida, T.; Takahashi, Y. Immunocytochemical localization of the allergenic proteins in the pollen of Cryptomeria japonica. Sex. Plant Reprod., 1994, 7(2), 95-100.
[http://dx.doi.org/10.1007/BF00230577]
[35]
Suzuki, M.; Komiyama, N.; Itoh, M.; Itoh, H.; Sone, T.; Kino, K.; Takagi, I.; Ohta, N. Purification, characterization and molecular cloning of Cha o 1, a major allergen of Chamaecyparis obtusa (Japanese cypress) pollen. Mol. Immunol., 1996, 33(4-5), 451-460.
[http://dx.doi.org/10.1016/0161-5890(95)00147-6] [PMID: 8676896]
[36]
Sakaguch, M.; Inouye, S.; Taniai, M.; Ando, S.; Usui, M.; Matuhasi, T. Identification of the second major allergen of Japanese cedar pol-len. Allergy, 1990, 45(4), 309-312.
[http://dx.doi.org/10.1111/j.1398-9995.1990.tb00501.x] [PMID: 2382797]
[37]
Komiyama, N.; Sone, T.; Shimizu, K.; Morikubo, K.; Kino, K. cDNA cloning and expression of Cry j II the second major allergen of Jap-anese cedar pollen. Biochem. Biophys. Res. Commun., 1994, 201(2), 1021-1028.
[http://dx.doi.org/10.1006/bbrc.1994.1804] [PMID: 8002972]
[38]
Ohtsuki, T.; Taniauchi, Y.; Kohno, K.; Fukuda, S.; Usui, M.; Kurimoto, M. Cry j 2, a major allergen of Japanese cedar pollen, shows polymethylgalacturonase activity. Allergy, 1995, 50(6), 483-488.
[http://dx.doi.org/10.1111/j.1398-9995.1995.tb01183.x] [PMID: 7573841]
[39]
Nakamura, S.; Sato, F.; Nakamura, N. Immunocytochemical localization of cry j 1 and cry j 2: the allergenic proteins of japanese cedar pollen: In the germinated pollen. Jpn. J. Palynol., 2004, 50(1), 15-22.
[http://dx.doi.org/10.24524/jjpal.50.1_15]
[40]
Mori, T.; Yokoyama, M.; Komiyama, N.; Okano, M.; Kino, K. Purification, identification, and cDNA cloning of Cha o 2, the second major allergen of Japanese cypress pollen. Biochem. Biophys. Res. Commun., 1999, 263(1), 166-171.
[http://dx.doi.org/10.1006/bbrc.1999.1261] [PMID: 10486272]
[41]
Yasueda, H.; Saito, A.; Sakaguchi, M.; Ide, T.; Saito, S.; Taniguchi, Y.; Akiyama, K.; Inouye, S. Identification and characterization of a group 2 conifer pollen allergen from Chamaecyparis obtusa, a homologue of Cry j 2 from Cryptomeria japonica. Clin. Exp. Allergy, 2000, 30(4), 546-550.
[http://dx.doi.org/10.1046/j.1365-2222.2000.00747.x] [PMID: 10718852]
[42]
Fujimura, T.; Futamura, N.; Midoro-Horiuti, T.; Togawa, A.; Goldblum, R.M.; Yasueda, H.; Saito, A.; Shinohara, K.; Masuda, K.; Kurata, K.; Sakaguchi, M. Isolation and characterization of native Cry j 3 from Japanese cedar (Cryptomeria japonica) pollen. Allergy, 2007, 62(5), 547-553.
[http://dx.doi.org/10.1111/j.1398-9995.2007.01331.x] [PMID: 17441795]
[43]
Midoro-Horiuti, T.; Goldblum, R.M.; Kurosky, A.; Wood, T.G.; Brooks, E.G. Variable expression of pathogenesis related protein allergen in mountain cedar (Juniperus ashei) pollen. J. Immunol., 2000, 164(4), 2188-2192.
[http://dx.doi.org/10.4049/jimmunol.164.4.2188] [PMID: 10657673]
[44]
Osada, T.; Maeda, M.; Tanabe, C.; Furuta, K.; Vavricka, C.J.; Sasaki, E.; Okano, M.; Kimura, Y. Glycoform of a newly identified pollen allergen, Cha o 3, from Chamaecyparis obtusa (Japanese cypress, Hinoki). Carbohydr. Res., 2017, 448, 18-23.
[http://dx.doi.org/10.1016/j.carres.2017.05.005] [PMID: 28575723]
[45]
Osada, T.; Tanaka, Y.; Yamada, A.; Sasaki, E.; Utsugi, T. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT. Allergol. Int., 2018, 67(4), 467-474.
[http://dx.doi.org/10.1016/j.alit.2018.02.004] [PMID: 29525489]
[46]
Palacín, A.; Rivas, L.A.; Gómez-Casado, C.; Aguirre, J.; Tordesillas, L.; Bartra, J.; Blanco, C.; Carrillo, T.; Cuesta-Herranz, J.; Bonny, J.A.C.; Flores, E.; García-Alvarez-Eire, M.G.; García-Nuñez, I.; Fernández, F.J.; Gamboa, P.; Muñoz, R.; Sánchez-Monge, R.; Torres, M.; Losada, S.V.; Villalba, M.; Vega, F.; Parro, V.; Blanca, M.; Salcedo, G.; Díaz-Perales, A. The involvement of thaumatin like proteins in plant food cross-reactivity: A multicenter study using a specific protein microarray. PLoS One, 2012, 7(9), e44088.
[http://dx.doi.org/10.1371/journal.pone.0044088] [PMID: 22970164]
[47]
Osada, T.; Yamada, A.; Sasaki, E.; Utsugi, T. Identification of dominant T-cell epitopes in the major Japanese cypress pollen allergen Cha o 3. Allergol. Int., 2020, 69(1), 141-143.
[http://dx.doi.org/10.1016/j.alit.2019.07.008] [PMID: 31420173]
[48]
Osada, T.; Harada, T.; Asaka, N.; Haruma, T.; Kino, K.; Sasaki, E.; Okano, M.; Yamada, A.; Utsugi, T. Identification and gene cloning of a new major allergen Cha o 3 from Chamaecyparis obtusa (Japanese cypress) pollen. J. Allergy Clin. Immunol., 2016, 138(3), 911-913.e7.
[http://dx.doi.org/10.1016/j.jaci.2016.03.026] [PMID: 27237746]
[49]
Ehrenberg, A.E.; Klingebiel, C.; Östling, J.; Larsson, H.; Mattsson, L.; Vitte, J.; Lidholm, J. Characterization of a 7 kDa pollen allergen belonging to the gibberellin regulated protein family from three Cupressaceae species. Clin. Exp. Allergy, 2020, 50(8), 964-972.
[http://dx.doi.org/10.1111/cea.13675] [PMID: 32506709]
[50]
Kiguchi, T.; Yamamoto-Hanada, K.; Saito-Abe, M.; Sato, M.; Irahara, M.; Ogita, H.; Miyagi, Y.; Inuzuka, Y.; Toyokuni, K.; Nishimura, K.; Ishikawa, F.; Miyaji, Y.; Kabashima, S.; Fukuie, T.; Narita, M.; Ohya, Y. Pollen-food allergy syndrome and component sensitization in adolescents: A Japanese population-based study. PLoS One, 2021, 16(4), e0249649.
[http://dx.doi.org/10.1371/journal.pone.0249649] [PMID: 33852622]
[51]
Lorenz, A.R.; Lüttkopf, D.; May, S.; Scheurer, S.; Vieths, S. The principle of homologous groups in regulatory affairs of allergen prod-ucts--a proposal. Int. Arch. Allergy Immunol., 2009, 148(1), 1-17.
[http://dx.doi.org/10.1159/000151243] [PMID: 18698143]
[52]
Konno, A.; Kubo, N. Patient satisfaction with the second generation antihistamines in the treatment of pollinosis and improved awareness on medical consultation-choice of drugs based on a large-scale questionnaire survey in patients with pollinosis. Prog. Med., 2008, 28(9), 2285-2296.
[53]
Nolte, H.; Bernstein, D.I.; Nelson, H.S.; Kleine-Tebbe, J.; Sussman, G.L.; Seitzberg, D.; Rehm, D.; Kaur, A.; Li, Z.; Lu, S. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial. J. Allergy Clin. Immunol., 2016, 138(6), 1631-1638.
[http://dx.doi.org/10.1016/j.jaci.2016.06.044] [PMID: 27521719]
[54]
Virchow, J.C.; Backer, V.; Kuna, P.; Prieto, L.; Nolte, H.; Villesen, H.H.; Ljørring, C.; Riis, B.; de Blay, F. Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma. JAMA, 2016, 315(16), 1715-1725.
[http://dx.doi.org/10.1001/jama.2016.3964] [PMID: 27115376]
[55]
Masuyama, K.; Okamoto, Y.; Okamiya, K.; Azuma, R.; Fujinami, T.; Riis, B.; Ohashi-Doi, K.; Natsui, K.; Imai, T.; Okubo, K. Efficacy and safety of SQ house dust mite sublingual immunotherapy tablet in Japanese children. Allergy, 2018, 73(12), 2352-2363.
[http://dx.doi.org/10.1111/all.13544] [PMID: 30043449]
[56]
Durham, S.R.; Emminger, W.; Kapp, A.; de Monchy, J.G.R.; Rak, S.; Scadding, G.K.; Wurtzen, P.A.; Andersen, J.S.; Tholstrup, B.; Riis, B.; Dahl, R. SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J. Allergy Clin. Immunol., 2012, 129(3), 717-725.e5.
[http://dx.doi.org/10.1016/j.jaci.2011.12.973] [PMID: 22285278]
[57]
Noon, L. Prophylactic inoculation against hay fever. Lancet, 1911, 177(4580), 1572-1573.
[http://dx.doi.org/10.1016/S0140-6736(00)78276-6]
[58]
Durham, S.R.; Leung, D.Y.M. One hundred years of allergen immunotherapy: Time to ring the changes. J. Allergy Clin. Immunol., 2011, 127(1), 3-7.
[http://dx.doi.org/10.1016/j.jaci.2010.11.032] [PMID: 21211638]
[59]
Matsuoka, T.; Shamji, M.H.; Durham, S.R. Allergen immunotherapy and tolerance. Allergol. Int., 2013, 62(4), 403-413.
[http://dx.doi.org/10.2332/allergolint.13-RAI-0650] [PMID: 24280670]
[60]
Ohashi-Doi, K.; Lund, K.; Mitobe, Y.; Okamiya, K. State of the Art: Development of a sublingual allergy immunotherapy tablet for allergic rhinitis in Japan. Biol. Pharm. Bull., 2020, 43(1), 41-48.
[http://dx.doi.org/10.1248/bpb.b19-00093] [PMID: 31902930]
[61]
Okubo, K.; Masuyama, K.; Imai, T.; Okamiya, K.; Stage, B.S.; Seitzberg, D.; Konno, A. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis. J. Allergy Clin. Immunol., 2017, 139(6), 1840-1848.
[http://dx.doi.org/10.1016/j.jaci.2016.09.043]
[62]
Durham, S.R.; Walker, S.M.; Varga, E.M.; Jacobson, M.R.; O’Brien, F.; Noble, W.; Till, S.J.; Hamid, Q.A.; Nouri-Aria, K.T. Long-term clinical efficacy of grass pollen immunotherapy. N. Engl. J. Med., 1999, 341(7), 468-475.
[http://dx.doi.org/10.1056/NEJM199908123410702] [PMID: 10441602]
[63]
Passalacqua, G. Specific immunotherapy: beyond the clinical scores. Ann. Allergy Asthma Immunol., 2011, 107(5), 401-406.
[http://dx.doi.org/10.1016/j.anai.2011.04.017] [PMID: 22018610]
[64]
Bousquet, J.; Lockey, R.; Malling, H. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J. Allergy Clin. Immunol., 1998, 102(4), 558-562.
[http://dx.doi.org/10.1016/S0091-6749(98)70271-4] [PMID: 9802362]
[65]
Ohashi-Doi, K.; Kito, H.; Du, W.; Nakazawa, H.; Ipsen, H.; Gudmann, P.; Lund, K. Bioavailability of house dust mite allergens in sublin-gual allergy tablets is highly dependent on the formulation. Int. Arch. Allergy Immunol., 2017, 174(1), 26-34.
[http://dx.doi.org/10.1159/000479693] [PMID: 28950271]
[66]
Lund, K.; Kito, H.; Skydtsgaard, M.B.; Nakazawa, H.; Ohashi-Doi, K.; Lawton, S. The importance of tablet formulation on allergen release kinetics and efficiency: Comparison of freeze-dried and compressed grass pollen sublingual allergy immunotherapy tablet formulations. Clin. Ther., 2019, 41(4), 742-753.
[http://dx.doi.org/10.1016/j.clinthera.2019.02.008] [PMID: 30885398]
[67]
Watanabe, A.; Yamamoto, T.; Matsuhara, H.; Matsui, H.; Nakazawa, H.; Lund, K.; Ohashi-Doi, K. Allergen stability and immunological reactivity during co-dissolution and incubation of house dust mite and Japanese cedar pollen SLIT-tablets. Biol. Pharm. Bull., 2020, 43(10), 1448-1450.
[http://dx.doi.org/10.1248/bpb.b20-00330] [PMID: 32759600]
[68]
Du, W.; Maekawa, Y.; Natsui, K. Developmental history of sublingual immunotherapy. Nippon Yakurigaku Zasshi, 2019, 154(1), 6-11.
[http://dx.doi.org/10.1254/fpj.154.6] [PMID: 31308350]
[69]
Malling, H.J. WHO position paper (summary)-allergen immunotherapy: Therapeutic vaccines for allergic diseases. Wien. Med. Wochenschr., 1999, 149(14-15), 410-414.
[PMID: 10584284]
[70]
Yasueda, H.; Okuda, M.; Yoshida, H.; Ito, K.; Baba, M.; Iikura, Y.; Okudaira, H.; Inoue, S.; Sakaguchi, M.; Miyamoto, T. A basic policy for allergen standerdization in our country and standardization of Japanese cedar (Cryptomeria japonica) pollen extracts. Allergol. Int., 1997, 46(2), 135-140.
[http://dx.doi.org/10.2332/allergolint.46.135]
[71]
Torii Pharmaceutical Co., Ltd.. Comprehensive Drug Information: Therapeutic Standardized Allergen Extract Subcutaneous Injection "Torii" Cedar Pollen (in Japanese). Available from: https://www.torii.co.jp/iyakuDB/data/if/if_alg_t_sa.pdf
[72]
Horiguchi, S.; Okamoto, Y.; Yonekura, S.; Okawa, T.; Yamamoto, H.; Kunii, N.; Sakurai, D.; Fujimura, T.; Nakazawa, K.; Yasueda, H. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis. Int. Arch. Allergy Immunol., 2008, 146(1), 76-84.
[http://dx.doi.org/10.1159/000112506] [PMID: 18087165]
[73]
Okamoto, Y.; Okubo, K.; Yonekura, S.; Hashiguchi, K.; Goto, M.; Otsuka, T.; Murata, T.; Nakao, Y.; Kanazawa, C.; Nagakura, H.; Okawa, T.; Nakano, K.; Hisamitsu, M.; Kaneko, S.; Konno, A. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis. Int. Arch. Allergy Immunol., 2015, 166(3), 177-188.
[http://dx.doi.org/10.1159/000381059] [PMID: 25895909]
[74]
Yonekura, S.; Gotoh, M.; Kaneko, S.; Kanazawa, K.; Takeuji, Y.; Okubo, K.; Okamoto, Y. Treatment duration-dependent efficacy of Jap-anese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons. Allergol. Int., 2019, 68(4), 494-505.
[http://dx.doi.org/10.1016/j.alit.2019.05.002] [PMID: 31257168]
[75]
Nomura, Y.; Okubo, K.; Nakamura, T.; Sawaki, S.; Kitagou, H.; Idei, N.; Kaneko, S.; Kobayashi, S.; Tanaka, Y.; Okamoto, Y. Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clini-cal trial. Allergol. Int., 2021, 70(1), 96-104.
[http://dx.doi.org/10.1016/j.alit.2020.05.008] [PMID: 32653209]
[76]
Yasueda, H.; Okuda, M.; Yoshida, H.; Ito, K.; Baba, M.; Iikura, Y.; Okudaira, H.; Inoue, S.; Sakaguchi, M.; Miyamoto, T. Basic policy of allergen standardization and standardization of Japanese cedar pollen allergen extracts in Japan. Arerugi, 1996, 45(4), 416-421.
[http://dx.doi.org/10.15036/arerugi.45.416] [PMID: 8687291]
[77]
Takai, T.; Okamoto, Y.; Okubo, K.; Nagata, M.; Sakaguchi, M.; Fukutomi, Y.; Saito, A.; Yasueda, H.; Masuyama, K. Japanese society of allergology task force report on standardization of house dust mite allergen vaccines. Arerugi, 2014, 63(9), 1229-1240.
[PMID: 25492878]
[78]
Takai, T.; Okamoto, Y.; Okubo, K.; Nagata, M.; Sakaguchi, M.; Fukutomi, Y.; Saito, A.; Yasueda, H.; Masuyama, K. Japanese society of allergology task force report on standardization of house dust mite allergen vaccines-secondary publication. Allergol. Int., 2015, 64(2), 181-186.
[http://dx.doi.org/10.1016/j.alit.2015.01.005] [PMID: 25838095]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy